Moolec Science (MLEC) Change in Working Capital (2023 - 2024)

Moolec Science's (MLEC) quarterly Change in Working Capital came in at -$2.7 million in Q4 2024, down 73.97% year-on-year from -$10.2 million in Q1 2024, and down 73.97% quarter-over-quarter from -$1.5 million in Q4 2023.

Moolec Science (MLEC) Change in Working Capital (2023 - 2024) Analysis & Trends

Moolec Science has disclosed Change in Working Capital across 2 years of filings, most recently posting -$2.7 million for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Moolec Science 6.98 Bn 6.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.66 Mn
Dec 31, 2024 -2.66 Mn
Dec 31, 2023 -1.53 Mn
Dec 31, 2023 -1.53 Mn